Association Between Statin Use and Sex Hormone in the Multi-Ethnic Study of Atherosclerosis Cohort
- 3 June 2019
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 104 (10) , 4600-4606
Abstract
Purpose Based on the 2018 American College of Cardiology/American Heart Association cholesterol guidelines, the number of individuals eligible for statin therapy to reduce atherosclerotic cardiovascular disease risk has greatly expanded. Statins inhibit cholesterol biosynthesis, which can impair gonadal steroidogenesis. We evaluated the effect of statins on endogenous sex hormones in a large epidemiological study. Methods A total of 6814 Multi-Ethnic Study of Atherosclerosis (MESA) participants underwent the baseline examination. Of these, 6171 had measurements of serum sex hormones available: dehydroepiandrosterone (DHEA), SHBG, estradiol, and total and bioavailable testosterone. Multivariable linear regression models were used to assess the relationship of statin use with each sex hormone. Results A total of 345 women (17.4%) and 464 men (14.7%) were statin users (mean age, 67 years; 41% white, 29% black, 11% Chinese, and 19% Hispanic). Among the users vs nonusers of statins, the mean SHBG was 3.54 nmol/L (P < 0.01) lower in women and 3.37 nmol/L (P < 0.001) lower in men; the mean DHEA was 1.06 nmol/L (P < 0.05) lower in women and 0.70 nmol/L (P < 0.01) lower in men, after adjustment for potential confounders. With further propensity score adjustment, the mean DHEA and SHBG levels were 0.67 nmol/L (P < 0.05) and 3.49 nmol/L (P < 0.001) lower, respectively, for statin users vs nonusers. No statistically significant association was noted between estradiol, total testosterone, and bioavailable testosterone and statin use. Conclusion Statin users have lower levels of SHBG and DHEA. This is especially relevant owing to the increasing use of statin therapy.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01-HL-074406, R01-HL-074338, HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169)
This publication has 31 references indexed in Scilit:
- Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosisBMC Medical Research Methodology, 2013
- Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES IIICancer Causes & Control, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health SurveyCancer Epidemiology, Biomarkers & Prevention, 2007
- Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 DiabetesDiabetes Care, 2007
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Testicular Function in Hypercholesterolemic Male Patients During Prolonged Simvastatin TreatmentHormone and Metabolic Research, 1996